DOPATREE
Preview
Open in TheBrain
DOPATREE
EMA PHARMACOVIGILANCE PLANS / RELATED
EMA PHARMACOVIGILANCE ACTIVITIES
EMA PHARMACOVIGILANCE ACTIVITIES / LISTINGS / ADDITIONAL
CLINICAL STUDIES-ALL (CLINICAL TRIALS, STUDY, PROTOCOLS, MASTER PROTOCOLS, CLINICAL OPERATIONS, CLINICAL STUDY DESIGNS, COVARIATES, CONTINUOUS OUTCOMES, ICH E8, ENRICHMENT, STUDY REPORT, HOLD, CLINICAL INVESTIGATIONS)
CLINICAL STUDIES / TYPES
PHARMACOEPIDEMIOLOGY STUDY (STUDIES)
PHARMACOEPIDEMIOLOGY STUDY / RELATED
SAFETY STUDY (SAFETY PHARMACOLOGY, CHRONIC TOXICITY, TOXICOKINETICS, TOXICOLOGY, PHARMACOEPI, CLINICAL, NONCLINICAL, NON-CLINICAL, PRECLINICAL, LONG-TERM, LTSS, SAFETY DATA, SAFETY STUDIES)
SAFETY STUDY / RELATED
Parents
SAFETY STUDY (SAFETY PHARMACOLOGY, CHRONIC TOXICITY, TOXICOKINETICS, TOXICOLOGY, PHARMACOEPI, CLINICAL, NONCLINICAL, NON-CLINICAL, PRECLINICAL, LONG-TERM, LTSS, SAFETY DATA, SAFETY STUDIES)
Children
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)